Janux Therapeutics, Inc.JANXNASDAQ
Loading
Gross Margin Over TimeContracting
Percentile Rank33
3Y CAGR-19.4%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-19.4%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM47.20%-41.4%
202480.54%+6.2%
202375.81%-16.0%
202290.23%-9.8%
2021100.00%-
20200.00%-
20190.00%-